OBJECTIVES: This study was conducted to evaluate the added value of an enhanced recovery after surgery (ERAS) programme in laparoscopic liver resections for solid tumours. METHODS: Patients undergoing laparoscopic liver resection between July 2005 and July 2008 were included. Indications for resections included presumed benign and malignant liver lesions. Primary outcome was total length of hospital stay (LOS). Secondary outcomes were functional recovery, complications, conversions, blood loss and duration of operation. RESULTS: Thirteen patients were treated by laparoscopic liver resections in the ERAS programme in one centre (group 1). Their outcomes were compared with outcomes of 13 laparoscopic procedures performed either before the introduction of the ERAS programme during 2003-2005 in the same centre or during the same period in other centres using traditional care (group 2). Median total LOS was 5.0 days (range 3-10 days) in group 1 and 7.0 days (3-12 days) in group 2. This difference was not statistically significant. Functional recovery occurred 2 days earlier in group 1 (median 3.0 days [range 1-7 days] vs. median 5.0 days [range 2-8 days]; P < 0.044). There were no significant differences in complications, conversions or duration of operation. Blood loss was significantly less in the ERAS group (median 50 ml [range 50-200 ml] vs. median 250 ml [range 50-800 ml]; P < 0.002). CONCLUSIONS: This exploratory, multicentre, fast-track laparoscopic liver resection study is the first such study conducted. Although small, the study suggests that a multimodal enhanced recovery programme in laparoscopic liver surgery is feasible, safe and may lead to accelerated functional recovery and reductions in LOS.
OBJECTIVES: This study was conducted to evaluate the added value of an enhanced recovery after surgery (ERAS) programme in laparoscopic liver resections for solid tumours. METHODS:Patients undergoing laparoscopic liver resection between July 2005 and July 2008 were included. Indications for resections included presumed benign and malignant liver lesions. Primary outcome was total length of hospital stay (LOS). Secondary outcomes were functional recovery, complications, conversions, blood loss and duration of operation. RESULTS: Thirteen patients were treated by laparoscopic liver resections in the ERAS programme in one centre (group 1). Their outcomes were compared with outcomes of 13 laparoscopic procedures performed either before the introduction of the ERAS programme during 2003-2005 in the same centre or during the same period in other centres using traditional care (group 2). Median total LOS was 5.0 days (range 3-10 days) in group 1 and 7.0 days (3-12 days) in group 2. This difference was not statistically significant. Functional recovery occurred 2 days earlier in group 1 (median 3.0 days [range 1-7 days] vs. median 5.0 days [range 2-8 days]; P < 0.044). There were no significant differences in complications, conversions or duration of operation. Blood loss was significantly less in the ERAS group (median 50 ml [range 50-200 ml] vs. median 250 ml [range 50-800 ml]; P < 0.002). CONCLUSIONS: This exploratory, multicentre, fast-track laparoscopic liver resection study is the first such study conducted. Although small, the study suggests that a multimodal enhanced recovery programme in laparoscopic liver surgery is feasible, safe and may lead to accelerated functional recovery and reductions in LOS.
Authors: K C H Fearon; O Ljungqvist; M Von Meyenfeldt; A Revhaug; C H C Dejong; K Lassen; J Nygren; J Hausel; M Soop; J Andersen; H Kehlet Journal: Clin Nutr Date: 2005-04-21 Impact factor: 7.324
Authors: J Wind; S W Polle; P H P Fung Kon Jin; C H C Dejong; M F von Meyenfeldt; D T Ubbink; D J Gouma; W A Bemelman Journal: Br J Surg Date: 2006-07 Impact factor: 6.939
Authors: J Maessen; C H C Dejong; J Hausel; J Nygren; K Lassen; J Andersen; A G H Kessels; A Revhaug; H Kehlet; O Ljungqvist; K C H Fearon; M F von Meyenfeldt Journal: Br J Surg Date: 2007-02 Impact factor: 6.939
Authors: R M van Dam; P O Hendry; M M E Coolsen; M H A Bemelmans; K Lassen; A Revhaug; K C H Fearon; O J Garden; C H C Dejong Journal: Br J Surg Date: 2008-08 Impact factor: 6.939
Authors: Linda Basse; Dorthe Hjort Jakobsen; Linda Bardram; Per Billesbølle; Claus Lund; Torben Mogensen; Jacob Rosenberg; Henrik Kehlet Journal: Ann Surg Date: 2005-03 Impact factor: 12.969
Authors: Constantinos Simillis; Vasilis A Constantinides; Paris P Tekkis; Ara Darzi; Richard Lovegrove; Long Jiao; Anthony Antoniou Journal: Surgery Date: 2006-09-25 Impact factor: 3.982
Authors: Lidewij Spelt; Daniel Ansari; Christian Sturesson; Bobby Tingstedt; Roland Andersson Journal: HPB (Oxford) Date: 2011-09-26 Impact factor: 3.647
Authors: Lucas W Thornblade; Yongwoo D Seo; Tracy Kwan; Jane H Cardoso; Eric Pan; Gregory Dembo; Raymond S W Yeung; James O Park Journal: J Gastrointest Surg Date: 2018-02-05 Impact factor: 3.452
Authors: Nicolai A Schultz; Peter N Larsen; B Klarskov; L M Plum; Hans-Jørgen Frederiksen; Henrik Kehlet; Jens G Hillingsø Journal: World J Surg Date: 2018-06 Impact factor: 3.352
Authors: Belinda Sánchez-Pérez; José Manuel Aranda-Narváez; Miguel Angel Suárez-Muñoz; Moises Eladel-Delfresno; José Luis Fernández-Aguilar; Jose Antonio Pérez-Daga; Ysabel Pulido-Roa; Julio Santoyo-Santoyo Journal: World J Gastrointest Surg Date: 2012-11-27
Authors: Mariëlle M E Coolsen; Edgar M Wong-Lun-Hing; Ronald M van Dam; Aart A van der Wilt; Karem Slim; Kristoffer Lassen; Cornelis H C Dejong Journal: HPB (Oxford) Date: 2012-09-28 Impact factor: 3.647